DPIIT recognised startup Government of India
Startup India
Medrix Labs Private Limited - pharma in Rajpura, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.63 Cr
▲ 42% YoY
Net profit · FY 2024
₹3.49 Lakh
Net margin 1%
EBITDA · FY 2024
₹8.38 Lakh
EBITDA margin 2.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹10 Lakh
No open charges
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Medrix Labs Private Limited
Data last updated:
Medrix Labs Private Limited is a private limited company based in Rajpura, Punjab, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24290PB2020PTC051613. Its GSTIN is 06AANCM6753E1Z9 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rohit Sharma and Karamjit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rajpura, Punjab.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.63 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹3.49 Lakh (net margin 1%) and EBITDA of ₹8.38 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 76% over three years.
The company is associated with 1 brand: Medrix Labs. As per MCA filings, the company has satisfied charges of ₹10 Lakh on record.
Medrix Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0000732). For more details, the company can be reached via its website medrixlabs.com.
Company details
CIN U24290PB2020PTC051613
Registration Number 051613
Incorporation Date 11 August 2020
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0000732
Recognitions & Rankings of Medrix Labs
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0000732
Contact details
Medrix Labs Private Limited's registered office is in Rajpura, Punjab. Its website is medrixlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSCO 3 3rd Floor, Ss Emporium Plaza, Rajpura, Punjab, India – 140603
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medrix Labs Private Limited, buy the company report.
Comprehensive company report
Medrix Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medrix Labs operates one associated brand: Medrix Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medrix Labs offers contract manufacturing services for a variety of pharmaceutical products as a third-party provider. | medrixlabs.com |
Business activity
The main business activity of Medrix Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medrix Labs Private Limited, buy the company report.
Financials of Medrix Labs Private Limited
FY 2025 filings availableMedrix Labs Private Limited reported revenue of ₹3.63 Cr (up 42% YoY) for FY 2024.
Revenue · FY 2024
₹3.63 Cr ▲ 42%
Net profit · FY 2024
₹3.49 Lakh margin 1%
EBITDA · FY 2024
₹8.38 Lakh margin 2.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 76%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 75%
Revenue has grown at a compounded annual rate (CAGR) of 76% over three years, including 42% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹8.38 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹3.49 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.3% | |||
| Net Profit Margin | 1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medrix Labs Private Limited, buy the company report.
Board of directors of Medrix Labs Private Limited
Medrix Labs has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Sharma Also directs: Innovexia Life Sciences Private Limited | Director | 11 Aug 2020 | 6 Years 2 Months | Current |
| Karamjit | Director | 11 Aug 2020 | 6 Years 2 Months | Current |
| Vikram Arora | Director | 01 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Medrix Labs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nirdhara Chemical Private Limited | ₹3.64 Cr (FY 2025) | 206.0% | Surat, Gujarat, India | |||
| Galvan Chemicals Private Limited | ₹3.63 Cr (FY 2025) | 0.0% | Chennai, Tamil Nadu, India | |||
| Thakur Ayurvedic Pharmacy Private Limited | ₹3.63 Cr (FY 2022) | 10.0% | Mumbai, Maharashtra, India | |||
| Nutrimed Healthcare Private Limited | ₹3.63 Cr (FY 2025) | -46.0% | New Delhi, Delhi, India | |||
| Vasuki Colour Anodise Private Limited | ₹3.63 Cr (FY 2025) | -28.0% | Rajkot, Gujarat, India | |||
| Medrix Labs Private Limitedthis company | ₹3.63 Cr (FY 2024) | ₹3.49 Lakh | 1% | 42.0% | Rajpura, Punjab, India | |
| Parthvimeda Gau Pharma Private Limited | ₹3.63 Cr (FY 2025) | 42698.0% | Ahmedabad, Gujarat, India | |||
| Khandige Organic Health Products Private Limited | ₹3.63 Cr (FY 2024) | -7.0% | Bangalore, Karnataka, India | |||
| Woodlaand Chemicals Private Limited | ₹3.62 Cr (FY 2025) | -52.0% | Delhi, India | |||
| Baxil Pharma Private Limited | ₹3.62 Cr (FY 2025) | -47.0% | Delhi, India | |||
| Agrifert India Private Limited | ₹3.62 Cr (FY 2025) | 69.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Medrix Labs Private Limited, buy the company report.
Auditor
Medrix Labs Private Limited is audited by AMIT K SHARMA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT K SHARMA & ASSOCIATES | FY 2021 | 021287N |
Shareholding
The shareholding of Medrix Labs Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medrix Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹10 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jan 2022 | 100535422 | State Bank of India | ₹10 Lakh | Satisfied |
To see the full charge records of Medrix Labs Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medrix Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medrix Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medrix Labs Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
Active EPFO establishments
1
GST
Medrix Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AANCM6753E1Z9 | Haryana | Active | 20 Aug 2020 |
To see the full GST registrations and return filing status of Medrix Labs Private Limited, buy the company report.
Recent activity
Medrix Labs Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Vikram Arora was appointed as Director on 01 May 2025.
AGM
Medrix Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Vikram Arora was appointed as Director.
Filing
Medrix Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge registered on 28 Jan 2022 via Charge ID 100535422 with State Bank Of India was fully satisfied on 21 Jan 2023.
Charges
A charge with State Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 100535422 was registered on 28 Jan 2022.
Appointed
Karamjit was appointed as Director.
Appointed
Rohit Sharma was appointed as Director.
Incorporation
11 Aug 2020
Medrix Labs Private Limited was registered on 11 Aug 2020 with Roc Chandigarh & aged 6 years 2 months as per MCA records.
Frequently asked questions
Medrix Labs is an active private limited company based in Rajpura, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2020 (6+ years old) and is registered under CIN U24290PB2020PTC051613.
Medrix Labs has 3 current directors:
- Rohit Sharma - Director
- Karamjit - Director
- Vikram Arora - Director
The latest financial statements of Medrix Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Medrix Labs is 06AANCM6753E1Z9, registered in Haryana.
The CIN (Corporate Identification Number) of Medrix Labs is U24290PB2020PTC051613. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medrix Labs was incorporated on 11 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Medrix Labs by revenue are Nirdhara Chemical Private Limited, Galvan Chemicals Private Limited, Thakur Ayurvedic Pharmacy Private Limited, Nutrimed Healthcare Private Limited, Vasuki Colour Anodise Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vikram Arora was appointed as Director on 01 May 2025. Karamjit was appointed as Director on 11 Aug 2020. Rohit Sharma was appointed as Director on 11 Aug 2020.
Yes, Medrix Labs is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Medrix Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0000732).
Medrix Labs can be reached through the website medrixlabs.com. Its registered office is in Rajpura, Punjab, India.